GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan · Delayed Price · Currency is TWD 16.70
-0.55 (-3.19%)
Aug 4, 2026, 1:30 PM CST
GeneReach Biotechnology Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 232.55 | 232.74 | 206.49 | 225.46 | 750.02 | 1,012 |
Revenue Growth | 9.16% | 12.71% | -8.42% | -69.94% | -25.89% | 18.09% |
Gross Profit Gross Profit Growth | 165.11 | 160.93 | 118.28 | 27.58 | 490.07 | 746.98 |
Operating Income Operating Income Growth | -70.83 | -79.86 | -131.22 | -229.29 | 241.34 | 482.35 |
Net Income Net Income Growth | -105.32 | -110.28 | -118.73 | -166.27 | 221.34 | 376.62 |
Earnings Per Share EPS Growth | -1.85 | -1.93 | -2.07 | -2.89 | 3.77 | 6.45 |
EPS Growth | - | - | - | - | -41.59% | 44.19% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Vietnam Vietnam Growth | 33.51 | 32.67 | 19.69 | 14.72 | 17.9 | 10.15 |
Taiwan Taiwan Growth | 31.88 | 30.32 | 27.29 | 32.4 | 441.93 | 468.59 |
Indonesia Indonesia Growth | 25.73 | 23.16 | 24.9 | 28.67 | 63.76 | 243.78 |
The Philippines The Philippines Growth | 22.03 | 22.18 | 10.03 | 11.91 | 13.78 | 10.44 |
India India Growth | 18.07 | 23.37 | 15.76 | 13.06 | 21.8 | 21.88 |
Other Countries Other Countries Growth | 74.68 | 75.3 | 43.49 | 28.59 | 33.18 | 18.53 |
Thailand Thailand Growth | - | - | 15.24 | 18 | 23.07 | 31.97 |
Saudi Arabia Saudi Arabia Growth | - | 13.58 | 18.71 | 8.08 | 9.88 | 54.17 |
Panama Panama Growth | - | 12.17 | 20.39 | 20.01 | 15.1 | 12.11 |
Mainland China Mainland China Growth | - | - | 10.98 | 19.35 | 22.69 | 60.08 |
Total Total Growth | 232.55 | 232.74 | 206.49 | 225.46 | 750.02 | 1,012 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 290.94 | 289.76 | 413.98 | 502.72 | 748.61 | 663.43 |
Total Debt Total Debt Growth | 215.54 | 219.1 | 267.23 | 248.74 | 389.95 | 369.78 |
Net Cash (Debt) Net Cash Growth | 75.4 | 70.67 | 146.75 | 253.98 | 358.66 | 293.65 |
Net Cash Growth | -61.46% | -51.84% | -42.22% | -29.19% | 22.14% | 133.48% |
Net Cash Per Share Net Cash Per Share Growth | 1.33 | 1.24 | 2.55 | 4.42 | 6.05 | 5.01 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -15.11 | -13.52 | -23.22 | -38.67 | 357.63 | 348.99 |
Capital Expenditures CapEx Growth | -5.99 | -6.36 | -7.12 | -23.53 | -49.87 | -19.56 |
Free Cash Flow Free Cash Flow Growth | -21.1 | -19.87 | -30.35 | -62.21 | 307.76 | 329.43 |
Free Cash Flow Growth | - | - | - | - | -6.58% | 206.11% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 71.00% | 69.14% | 57.28% | 12.23% | 65.34% | 73.81% |
Operating Margin | -30.46% | -34.31% | -63.55% | -101.70% | 32.18% | 47.66% |
Pretax Margin | -47.94% | -50.04% | -56.65% | -96.84% | 36.32% | 46.38% |
Profit Margin | -45.29% | -47.38% | -57.50% | -73.75% | 29.51% | 37.21% |
FCF Margin | -9.07% | -8.54% | -14.70% | -27.59% | 41.03% | 32.55% |
| Fiscal Year | FY 2022 | FY 2021 |
|---|---|---|
| Period Ending | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.200 | 3.636 |
Dividend Per Share Growth | -67.00% | 45.43% |
Dividend Yield | 2.34% | 6.03% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 13.71 | 10.07 |
Forward PE | - | 4.70 | 4.70 | 4.70 | 4.70 | 4.70 |
P/FCF Ratio | - | - | - | - | 9.86 | 11.52 |
PS Ratio | 4.12 | 4.66 | 7.97 | 10.05 | 4.05 | 3.75 |